Centogene (CNTGF, $0.16) was a top loser this month, diving -1 to $0.16 per share. Of the 422 stocks analyzed in the Medical Specialties Industry throughout this month, of them () exhibited an Uptrend while of them () were in a Downtrend.
a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies